Treatment of adult ADHD and comorbid depression (Q81487779)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567134%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Treatment of adult ADHD and comorbid depression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567134%20AND%20SRC:MED&resulttype=core&format=json

adult attention deficit hyperactivity disorder

9 January 2020

main subject

1 reference

Thomas J Spencer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567134%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567134%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567134%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567134%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

5 Suppl 8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567134%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

14-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567134%20AND%20SRC:MED&resulttype=core&format=json

Psychiatric comorbidity and response to two doses of methylphenidate in children with attention deficit disorder

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

An Open Trial of Venlafaxine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

Response of children with ADHD to methylphenidate: interaction with internalizing symptoms.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

The Personality Inventory for Children and response to methylphenidate: preliminary evidence for predictive utility

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

Bupropion treatment of attention-deficit hyperactivity disorder in adults

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

Effect of anxiety on cognition, behavior, and stimulant response in ADHD.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

Open-Label Treatment of Comorbid Depression and Attentional Disorders with Co-administration of Serotonin Reuptake Inhibitors and Psychostimulants in Children, Adolescents, and Adults: A Case Series

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002972

7 January 2021

10.1017/S1092852900002972

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567134%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference